A randomised study of intravenous bolus versus continuous infusion of ifosfamide and doxorubicin with oral etoposide for small-cell lung cancer.
Anderson, Heather Prendiville, Joseph A Thatcher, Nick Radford, John A Swindell, Ric
Anderson, Heather
Prendiville, Joseph A
Thatcher, Nick
Radford, John A
Swindell, Ric
Citations
Altmetric:
Abstract
159 "poor risk" patients with previously untreated small cell lung cancer were entered into a randomised study of intravenous bolus versus continuous infusion chemotherapy with doxorubicin on weeks 1, 3, 5 and ifosfamide with mesna on weeks 2, 4, 6. Oral etoposide was given on days 1-5, 15-19, and 29-33. There was no difference in response rate or survival. However, patients treated with continuous infusion therapy had significantly less haematological toxicity (P = 0.0007), and less nausea and vomiting (P = 0.03).
Description
Date
1991
Publisher
Collections
Keywords
Lung Cancer
Type
Article
Citation
A randomised study of intravenous bolus versus continuous infusion of ifosfamide and doxorubicin with oral etoposide for small-cell lung cancer. 1991, 117 Suppl 4:S139-40 J. Cancer Res. Clin. Oncol.